PTK2 and neoplasm: There is ample precedent for such co-administration strategies; for example, in vivo mouse studies have suggested that using Y15, a FAK autophosphorylation inhibitor, synergistically with temozolomide is a more effective at preventing tumor growth than either drug alone [17].